Embecta Corp. (EMBC): R&D Expense
$37.30M
Year ended 2025-09-30
$20.20M
Trailing 12 months to 2026-06-30
-17.7%
3-year compound annual growth
-9.5%
5-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-09-30 | $37.30M | -52.7% | 2025-11-25, From 2024-10-01 |
| 2024-09-30 | $78.80M | -7.5% | 2025-11-25, From 2023-10-01 |
| 2023-09-30 | $85.20M | +27.4% | 2025-11-25, From 2022-10-01 |
| 2022-09-30 | $66.90M | +5.7% | 2024-12-11, From 2021-10-01 |
| 2021-09-30 | $63.30M | +3.1% | 2023-11-29, From 2020-10-01 |
| 2020-09-30 | $61.40M | n/a | 2022-12-22, From 2019-10-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Embecta Corp. (EMBC) | 2025-09-30 | $37.30M | -52.7% |
| Tandem Diabetes Care Inc (TNDM) | 2025-12-31 | $193.11M | -2.9% |
| Inspire Medical Systems, Inc. (INSP) | 2025-12-31 | $103.17M | -9.6% |
| Haemonetics Corp (HAE) | 2026-03-28 | $59.77M | -4.7% |
| Penumbra Inc (PEN) | 2025-12-31 | $89.77M | -5.3% |
| Orthofix Medical Inc. (OFIX) | 2025-12-31 | $65.85M | -10.6% |
| Merit Medical Systems Inc (MMSI) | 2025-12-31 | $97.35M | +11.3% |
| Alphatec Holdings, Inc. (ATEC) | 2025-12-31 | $76.27M | -5.5% |
| iRhythm Holdings, Inc. (IRTC) | 2025-12-31 | $84.61M | +18.4% |
Compare EMBC, TNDM, INSP, HAE side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗